Skip to main content
. Author manuscript; available in PMC: 2019 Aug 4.
Published in final edited form as: Am J Med Genet A. 2015 Nov 30;170(3):594–601. doi: 10.1002/ajmg.a.37488

TABLE I.

Baseline Characteristics and Plasma Oxytocin Levels in Prader–Willi Syndrome and Healthy Unrelated Control Subjects

Prader-Willi syndrome (N = 23) Control subjects (N = 18)
Characteristic [mean±SD (range)] [mean ± SD (range)] F-value P-value
Age 8.2 ± 2.0 year (5–11 year) 8.2 ± 2.3 year (5–11 year) 0.07 0.79
BMI 20.7 ± 5.0 (l4–28) 18.2 ± 3.3 (15–25) 2.2 0.15
BMI z-score 0.96 ± 1.4 (13–32) 0.52 ± 1.35 (12–26) 1.1 0.31
Percent body fat 33 ± 13% (13–54%) 24 ± 10% (10–47%) 5.5 0.02*
Oxytocin levels [mean pg/ml ± SD (range, N)]
 All subjects 167 ± 121 (4.68–391, N = 23) 64.8 ± 83.8 (4.68–247, N = 18) 8.8 0.01*
 Female subjects (N = 18) 155 ± 141 (4.68–391, N = 10) 65.3 ± 84.4 (4.68–247, N = 8) 1.4 0.26
 Male subjects (N = 23) 172 ± 109 (4.68–332, N = 13) 64.3 ± 87.9 (4.68–245, N = 10) 9.3 0.01*
*

Indicated statistical significance.